Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR).

The oncolytic virus has been shown to shrink colon, lung, breast, ovarian and pancreatic cancer tumors in preclinical laboratory models.

Insulin is a vital hormone produced by pancreatic beta cells. Type 1 diabetes is caused by the destruction of these cells.

An artificial pancreas developed by a team of Cambridge researchers is helping protect very young children with type 1 diabetes.

More than 40 healthcare professionals and legal experts have issued the first guidance of its kind to support people with type 1 diabetes.